GO:0097110 scaffold protein binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0097110 scaffold protein binding is a molecular function describing the binding of a protein to a scaffold protein, which tethers multiple signaling components into complexes.
• Scaffold proteins are crucial regulators of key signaling pathways because they interact with multiple members of a pathway simultaneously.
• The FAK-paxillin interaction is a classic example of scaffold protein binding that can be targeted with high-throughput fluorescence polarization assays.
• Phase separation of zonula occludens proteins demonstrates how scaffold protein binding drives formation of tight junctions.
• Deep learning methods such as those reported by Wang et al. enable functional site scaffolding and protein design relevant to scaffold binding interfaces.
• Scaffold-client interactions can suppress aggregation of client proteins in model condensates, linking scaffold binding to protein homeostasis.
Description
Scaffold protein binding (GO:0097110) is a molecular function defined as binding to a scaffold protein, where scaffold proteins are crucial regulators of many key signaling pathways and are known to interact with and/or bind multiple members of a signaling pathway, tethering them into complexes. This term captures the physical interaction between a protein and a scaffold, a process that organizes signaling components in space and time. Understanding scaffold protein binding is essential because it underlies the assembly of multiprotein complexes that control cell proliferation, adhesion, and junction formation. Researchers study this function to dissect how signaling specificity is achieved and how disruption of scaffold interactions contributes to disease. The FAK-paxillin interaction is a well-characterized example of scaffold protein binding, and its detection has been adapted into high-throughput screening assays. Beyond classical signaling, scaffold protein binding is also relevant to phase separation phenomena, as shown for zonula occludens proteins that drive tight junction formation. In addition, computational and experimental protein design efforts have focused on constructing and scaffolding protein binding sites, highlighting the broad interest in this function.
scaffold protein binding At A Glance
| GO ID | GO:0097110 |
|---|---|
| GO term | scaffold protein binding |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Binding to a scaffold protein, which tethers multiple signaling pathway members into complexes |
| Example interaction | FAK-paxillin interaction, a target for high-throughput fluorescence polarization assays |
| Related cellular process | Phase separation of zonula occludens proteins drives tight junction formation |
| Research relevance | Scaffold-client interactions can suppress aggregation of client proteins in model condensates |
What Is GO:0097110?
GO:0097110 scaffold protein binding is the molecular function of selectively interacting with a scaffold protein. Scaffold proteins are not strictly defined by a single enzymatic activity; instead, they are characterized by their ability to bind and/or interact with multiple members of a signaling pathway, thereby tethering them into complexes. This binding event is central to the spatial organization of signaling molecules and can influence signal duration, specificity, and cellular outcomes.
Why Is scaffold protein binding Important in Cell Biology?
Scaffold protein binding is important because scaffold proteins are crucial regulators of many key signaling pathways, and their binding partners determine how signals are organized into complexes. This function impacts fundamental processes such as cell adhesion, junction formation, and protein homeostasis. Dysregulation of scaffold interactions can contribute to disease, and the FAK-paxillin interaction is a validated target for inhibitor discovery. Moreover, understanding scaffold binding enables protein design and synthetic biology applications, as demonstrated by deep learning approaches to scaffold functional sites.
• Scaffold protein binding organizes signaling components into complexes, which is essential for pathway specificity.
• The FAK-paxillin interaction is a model scaffold binding event used in high-throughput drug discovery.
• Phase separation of zonula occludens proteins via scaffold interactions drives tight junction formation.
• Scaffold-client interactions can suppress aggregation of client proteins, linking scaffold binding to proteostasis.
• Computational design of scaffold structures enables construction of novel protein binding sites.
• Deep learning methods can scaffold functional sites, advancing protein engineering.
• Phage display has been used to select protein-protein binding surfaces composed of anti-parallel alpha-helices and beta-sheets, relevant to scaffold interfaces.
• Nanobody-binding scaffolds (Legobodies) facilitate cryo-EM structure determination of small proteins, aiding structural studies of scaffold complexes.
• DNA-regulated multi-protein complement control demonstrates programmable assembly of protein complexes.
• Scaffold protein binding is a key consideration in designing synthetic signaling circuits and therapeutics.
Molecular Mechanism of scaffold protein binding
Recognition and Tethering of Signaling Components
In simple terms: Scaffold proteins act like molecular Velcro that holds several signaling proteins together.
Scaffold protein binding involves the recognition of a scaffold protein by one or more partner proteins, leading to tethering of multiple signaling pathway members into a complex. This tethering is crucial for regulating signaling pathways, as scaffold proteins interact with multiple members simultaneously. The FAK-paxillin interaction exemplifies how a scaffold binding event can be detected and quantified, forming the basis for high-throughput screening.
Phase Separation and Condensate Formation
In simple terms: Some scaffold proteins can form liquid-like droplets that concentrate signaling molecules.
Phase separation of zonula occludens proteins drives the formation of tight junctions, demonstrating that scaffold protein binding can lead to higher-order assembly through condensate formation. This process is a physical mechanism by which scaffold interactions organize cellular structures. Additionally, client-scaffold interactions can suppress aggregation of a client protein in model condensates, indicating a role in maintaining protein solubility.
Structural Basis of Scaffold Binding Interfaces
In simple terms: The shape and chemical properties of scaffold binding surfaces determine which partners can bind.
Protein binding sites can be constructed in scaffold structures, as shown by Liang et al., who designed binding sites within scaffold frameworks. Phage display has been used to select protein-protein binding surfaces composed of anti-parallel alpha-helices and beta-sheets, which are common structural motifs in scaffold interfaces. Deep learning methods have also been applied to scaffold functional sites, enabling the design of proteins with desired binding properties.
Regulation by Scaffold Availability and Post-Translational Modifications
In simple terms: The amount of scaffold protein and chemical tags on it can control how much binding occurs.
Scaffold protein binding is regulated by the availability of scaffold proteins and their binding partners, as well as by post-translational modifications that can alter interaction surfaces. The FAK-paxillin interaction is subject to regulation and can be targeted by inhibitors, highlighting its dynamic nature. DNA-regulated multi-protein complement control demonstrates that scaffold-mediated assembly can be programmed by external cues.
Scaffold-Assisted Structural Determination
In simple terms: Scaffolds can be used as tools to hold small proteins in place for imaging.
Nanobody-binding scaffolds (Legobodies) have been developed for cryo-EM structure determination of small proteins, illustrating how scaffold binding can be exploited to stabilize and visualize otherwise challenging targets. This application underscores the utility of scaffold protein binding in structural biology.
Key Genes Involved in GO:0097110 scaffold protein binding
The following genes and proteins are experimentally linked to scaffold protein binding or serve as key models for studying this function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PTK2 (FAK) | Non-receptor tyrosine kinase that binds paxillin | FAK-paxillin interaction is a model scaffold binding event for inhibitor screening |
| PXN (Paxillin) | Scaffold protein in focal adhesions | Binds FAK; target for fluorescence polarization assays |
| TJP1 (ZO-1) | Tight junction scaffold protein | Phase separation drives tight junction formation |
| TJP2 (ZO-2) | Tight junction scaffold protein | Component of zonula occludens phase separation |
| TJP3 (ZO-3) | Tight junction scaffold protein | Component of zonula occludens phase separation |
| SH3GLB1 | Endophilin B1, involved in membrane dynamics | Model for scaffold-client interactions in condensates |
| HSPB1 | Small heat shock protein | Client protein in scaffold aggregation studies |
| CRYAB | Small heat shock protein | Client protein in scaffold aggregation studies |
| VIM | Intermediate filament protein | Potential scaffold in cytoskeletal organization |
| ACTB | Actin, cytoskeletal protein | Common scaffold component in adhesion complexes |
| TLN1 | Talin, focal adhesion scaffold | Binds integrins and actin, relevant to scaffold binding |
| VCL | Vinculin, focal adhesion protein | Interacts with talin and actin, scaffold-like function |
| ITGB1 | Integrin beta 1 | Transmembrane receptor linking to scaffold proteins |
| SRC | Non-receptor tyrosine kinase | Binds scaffolds in signaling complexes |
| GRB2 | Adaptor protein | Scaffold-like adaptor in RTK signaling |
| MAPK1 | Mitogen-activated protein kinase 1 | Downstream of scaffold-organized pathways |
| MAPK3 | Mitogen-activated protein kinase 3 | Downstream of scaffold-organized pathways |
How Is scaffold protein binding Regulated?
Scaffold protein binding is regulated by the expression levels and localization of scaffold proteins, as well as by post-translational modifications that can create or disrupt binding interfaces. The FAK-paxillin interaction is a regulated event that can be modulated by inhibitors, indicating that scaffold binding is a druggable process. Phase separation of zonula occludens proteins is a regulated physical process that drives tight junction formation, suggesting that scaffold binding can be controlled by changes in local concentration and valency. Additionally, DNA-regulated multi-protein complement control demonstrates that scaffold-mediated assembly can be programmed by external nucleic acid cues.
scaffold protein binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTK2 (FAK) | Cancer progression and metastasis | Knockout of PTK2 in cancer cell lines to assess migration |
| PXN (Paxillin) | Focal adhesion signaling in cancer | Point mutation of paxillin binding site to disrupt FAK binding |
| TJP1 (ZO-1) | Epithelial barrier dysfunction | Knockout of TJP1 to study tight junction formation |
| SH3GLB1 | Protein aggregation and proteostasis | Overexpression in condensate models to test aggregation suppression |
| HSPB1 | Protein aggregation disorders | Knock-in of tagged HSPB1 to track client-scaffold interactions |
Cancer and Focal Adhesion Signaling
Scaffold protein binding is critical in focal adhesion signaling, where the FAK-paxillin interaction contributes to cell migration and proliferation. Dysregulation of this interaction is implicated in cancer progression, and high-throughput assays have been developed to identify inhibitors of the FAK-paxillin interaction. Targeting scaffold protein binding is therefore a potential therapeutic strategy in oncology.
Tight Junction Dysfunction and Epithelial Barrier Disorders
Phase separation of zonula occludens proteins drives tight junction formation, and disruption of this scaffold protein binding process can compromise epithelial barriers. Tight junction dysfunction is associated with various epithelial barrier disorders, making scaffold interactions in this context relevant to disease.
Protein Aggregation and Proteostasis
Client-scaffold interactions can suppress aggregation of a client protein in model condensates, linking scaffold protein binding to protein homeostasis. Impaired scaffold binding may contribute to aggregation-related pathologies, although direct disease associations require further study.
From scaffold protein binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of scaffold protein X disrupt signaling complex assembly? | Knockout cell model |
| Does a specific point mutation in the scaffold binding interface abolish interaction? | Point mutation knock-in cell model |
| Can a tagged scaffold protein be used to track complex formation in live cells? | Tagged knock-in cell model |
| Does overexpression of a scaffold protein enhance pathway activation? | Overexpression cell model |
| Which genes are required for scaffold protein binding-mediated phenotypes? | CRISPR library screening |
| What is the structural basis of scaffold binding? | Cryo-EM with nanobody-binding scaffolds |
How to Study the scaffold protein binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence polarization | Binding affinity and inhibition of scaffold interactions | High-throughput screening for FAK-paxillin inhibitors |
| Cryo-EM with Legobodies | Three-dimensional structure of small proteins | Structural determination of scaffold complexes |
| Phase separation imaging | Formation and dynamics of condensates | Studying tight junction assembly |
| Deep learning protein design | Prediction and design of functional sites | Scaffolding binding interfaces |
| Phage display | Selection of binding surfaces | Identifying scaffold-binding peptides |
| DNA-regulated assembly | Programmable multi-protein complex formation | Controlling complement activation |
| Aggregation assays | Client protein aggregation in condensates | Testing scaffold-mediated suppression |
| Protein binding site construction | De novo design of binding sites | Engineering scaffold structures |
Fluorescence Polarization Assays
High-throughput fluorescence polarization assays have been developed to detect inhibitors of the FAK-paxillin interaction, a model of scaffold protein binding. This method measures the change in polarization upon binding and is suitable for screening small molecule libraries.
Phase Separation and Condensate Imaging
Phase separation of zonula occludens proteins can be studied using imaging techniques to visualize condensate formation and tight junction assembly. Client-scaffold interactions in model condensates can also be monitored to assess aggregation suppression.
Protein Design and Deep Learning
Deep learning methods have been used to scaffold functional sites, enabling the design of proteins with tailored binding properties. Construction of protein binding sites in scaffold structures provides a rational approach to engineer novel interactions.
Phage Display and Structural Biology
Phage display has been employed to select protein-protein binding surfaces composed of anti-parallel alpha-helices and beta-sheets, which can inform scaffold interface design. Nanobody-binding scaffolds (Legobodies) facilitate cryo-EM structure determination of small proteins, aiding structural analysis of scaffold complexes.
How CRISPR Can Be Used to Study GO:0097110 scaffold protein binding
Knockout
CRISPR knockout of genes encoding scaffold proteins or their binding partners can abolish specific scaffold protein binding events, allowing researchers to assess downstream signaling and phenotypic consequences. For example, knocking out PTK2 or PXN can disrupt the FAK-paxillin interaction.
Point Mutation
CRISPR point mutation can be used to introduce specific amino acid substitutions at scaffold binding interfaces to test the functional relevance of individual residues. This approach enables precise dissection of binding determinants without altering protein expression levels.
Knock-in
CRISPR knock-in of tags or reporter sequences into scaffold protein genes allows real-time tracking of scaffold protein binding and complex assembly in live cells. Tagged knock-in models are valuable for imaging phase-separated condensates and junction formation.
Overexpression
CRISPR-mediated overexpression of scaffold proteins or their binding partners can amplify scaffold protein binding events, facilitating biochemical and structural studies. Overexpression models are also useful for testing whether increased scaffold availability enhances pathway activation.
How EDITGENE Supports scaffold protein binding Research
Researchers studying scaffold protein binding-related genes often need to determine whether a candidate gene is causally involved in complex assembly, signaling, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for scaffold protein binding research.
Frequently Asked Questions About scaffold protein binding
What is GO:0097110 scaffold protein binding?
GO:0097110 scaffold protein binding is a molecular function defined as binding to a scaffold protein, which tethers multiple signaling pathway members into complexes.
What genes are involved in scaffold protein binding?
Genes such as PTK2 (FAK), PXN (paxillin), and TJP1 (ZO-1) encode proteins that participate in scaffold protein binding.
How is scaffold protein binding studied?
It is studied using methods like fluorescence polarization assays, phase separation imaging, and CRISPR-based genetic screens.
Why is scaffold protein binding important in cancer?
The FAK-paxillin scaffold interaction contributes to cancer cell migration and proliferation, making it a therapeutic target.
What is an example of scaffold protein binding?
The FAK-paxillin interaction is a classic example of scaffold protein binding.
Can scaffold protein binding be targeted by drugs?
Yes, high-throughput assays have been developed to detect inhibitors of the FAK-paxillin interaction, demonstrating druggability.
How does phase separation relate to scaffold protein binding?
Phase separation of zonula occludens proteins drives tight junction formation, showing that scaffold binding can lead to condensate assembly.
What CRISPR models are available for scaffold protein binding research?
Knockout, point mutation, knock-in, and overexpression models can be generated to study scaffold protein binding.
What is the role of scaffold proteins in signaling?
Scaffold proteins interact with multiple members of a signaling pathway, tethering them into complexes to regulate signaling.
How can I screen for regulators of scaffold protein binding?
CRISPR library screening can identify genes that modulate scaffold protein binding and downstream phenotypes.
Conclusion
GO:0097110 scaffold protein binding is a fundamental molecular function that organizes signaling complexes and cellular structures. From the FAK-paxillin interaction to phase-separated tight junctions, scaffold protein binding underlies diverse biological processes and is implicated in cancer and barrier disorders. Continued research using CRISPR models and advanced imaging will further illuminate how scaffold interactions are regulated and how they can be targeted therapeutically.
References
- 1. Marlowe T et al.. 2020. Development of a High-Throughput Fluorescence Polarization Assay to Detect Inhibitors of the FAK-Paxillin Interaction.. SLAS Discov 25(1):21-32 PMID: 31513463
- 2. Wu X et al.. 2021. Cryo-EM structure determination of small proteins by nanobody-binding scaffolds (Legobodies).. Proc Natl Acad Sci U S A 118(41) PMID: 34620716
- 3. Beutel O et al.. 2019. Phase Separation of Zonula Occludens Proteins Drives Formation of Tight Junctions.. Cell 179(4):923-936.e11 PMID: 31675499
- 4. Liang S et al.. 2000. Construction of protein binding sites in scaffold structures.. Biopolymers 54(7):515-23 PMID: 10984403
- 5. Zhu N et al.. 2024. Utility of protein-protein binding surfaces composed of anti-parallel alpha-helices and beta-sheets selected by phage display.. J Biol Chem 300(5):107283 PMID: 38608728
- 6. Wang J et al.. 2022. Scaffolding protein functional sites using deep learning.. Science 377(6604):387-394 PMID: 35862514
- 7. Ma Y et al.. 2024. DNA-Regulated Multi-Protein Complement Control.. J Am Chem Soc 146(48):32912-32918 PMID: 39569872
- 8. Ahmed R et al.. 2025. Client-scaffold interactions suppress aggregation of a client protein in model condensates.. Proc Natl Acad Sci U S A 122(33):e2508403122 PMID: 40794831
